Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,001 | -15,443 | -80,534 | -63,727 | -41,101 |
| Depreciation Amortization | 61 | 31 | 778 | 314 | 208 |
| Accounts payable and accrued liabilities | -1,456 | -913 | -101 | 2,035 | 3,126 |
| Other Working Capital | 989 | -124 | -2,627 | 2,747 | 2,828 |
| Other Operating Activity | 10,136 | 5,064 | 14,526 | 8,119 | 2,831 |
| Operating Cash Flow | $-20,271 | $-11,385 | $-67,958 | $-50,512 | $-32,108 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,631 | 10,009 | 5,521 | -14,183 | 28,833 |
| PPE Investments | -20 | -13 | -283 | -230 | -205 |
| Investing Cash Flow | $16,611 | $9,996 | $5,238 | $-14,413 | $28,628 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,177 | 1,175 | 9,207 | 9,185 | 6,073 |
| Other Financing Activity | 0 | 0 | 57,500 | 57,500 | 20,000 |
| Financing Cash Flow | $1,177 | $1,175 | $66,707 | $66,685 | $26,073 |
| Beginning Cash Position | 19,859 | 19,859 | 15,872 | 15,872 | 15,872 |
| End Cash Position | 17,376 | 19,645 | 19,859 | 17,632 | 38,465 |
| Net Cash Flow | $-2,483 | $-214 | $3,987 | $1,760 | $22,593 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,271 | -11,385 | -67,958 | -50,512 | -32,108 |
| Capital Expenditure | -20 | -13 | -283 | -230 | -205 |
| Free Cash Flow | -20,291 | -11,398 | -68,241 | -50,742 | -32,313 |